Increasing Confidence in the Discovery of
Small Molecule Drugs

Select the most promising drug candidate earlier with our robust and translational iPSC-platform

Navigating through target identification and validation, assay development, high-throughput screening, hit identification, and lead optimization to the selection of a preclinical candidate is not an ordinary process. It is associated with a high risk of failure and its subsequent economic and social losses.

Human induced pluripotent stem cell (iPSC) technology (handled by the right experts) is a powerful platform to introduce translational assays and instill greater confidence at every stage of drug discovery. It can be patient-specific, replicate key disease phenotypes, and provide robust results in the context of high-throughput screening.